Humana (NYSE:HUM) Sets New 1-Year High – Here’s What Happened

Humana Inc. (NYSE:HUM)’s share price reached a new 52-week high during mid-day trading on Thursday . The company traded as high as $414.82 and last traded at $409.9230, with a volume of 1685093 shares trading hands. The stock had previously closed at $397.22.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the stock. Bank of America upped their price objective on shares of Humana from $340.00 to $380.00 and gave the stock a “neutral” rating in a research report on Wednesday, June 24th. Robert W. Baird dropped their target price on shares of Humana from $264.00 to $205.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 15th. Piper Sandler reissued a “neutral” rating and set a $254.00 target price (up from $182.00) on shares of Humana in a research note on Wednesday, May 13th. Mizuho upped their price target on shares of Humana from $335.00 to $390.00 and gave the stock an “outperform” rating in a research report on Monday, June 8th. Finally, Royal Bank Of Canada reaffirmed a “sector perform” rating on shares of Humana in a research note on Monday, June 1st. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, sixteen have issued a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $293.09.

Humana Trading Up 3.2%

The company’s 50 day moving average price is $314.71 and its two-hundred day moving average price is $248.64. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.77 and a quick ratio of 1.77. The stock has a market capitalization of $49.22 billion, a PE ratio of 43.84, a P/E/G ratio of 2.26 and a beta of 0.71.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.97 by $0.34. Humana had a net margin of 0.82% and a return on equity of 10.45%. The company had revenue of $39.65 billion during the quarter, compared to analysts’ expectations of $39.37 billion. During the same quarter in the prior year, the company earned $11.58 EPS. Humana’s revenue was up 23.5% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, analysts expect that Humana Inc. will post 9.04 earnings per share for the current year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be issued a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Friday, June 26th. Humana’s payout ratio is currently 37.86%.

Institutional Investors Weigh In On Humana

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. boosted its stake in Humana by 0.7% during the fourth quarter. Vanguard Group Inc. now owns 14,261,860 shares of the insurance provider’s stock worth $3,652,890,000 after buying an additional 106,030 shares during the last quarter. Capital International Investors increased its position in shares of Humana by 113.9% during the fourth quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock valued at $1,490,239,000 after acquiring an additional 3,097,571 shares during the last quarter. Pzena Investment Management LLC lifted its stake in Humana by 34.3% during the first quarter. Pzena Investment Management LLC now owns 5,470,982 shares of the insurance provider’s stock worth $948,614,000 after purchasing an additional 1,398,774 shares in the last quarter. State Street Corp boosted its position in shares of Humana by 1.8% during the fourth quarter. State Street Corp now owns 5,462,549 shares of the insurance provider’s stock worth $1,403,877,000 after buying an additional 97,211 shares during the period. Finally, Massachusetts Financial Services Co. MA boosted its position in shares of Humana by 28.9% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 4,496,775 shares of the insurance provider’s stock worth $1,151,759,000 after buying an additional 1,008,514 shares during the period. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.